Related Experiment Video
Updated: Aug 18, 2026
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of
1Department of Molecular Biology and Biochemistry, University of California, Irvine, California 92697-3900, USA.
Abstract:
Dysregulated stimulation of microglia, the resident macrophages in the brain, can lead to excessive induction of inflammatory agents and subsequently damage to neurons. Fibrillar beta-amyloid peptide (fA beta), a major component of senile plaques in Alzheimer's disease (AD) brain, is known to induce microglial-mediated neurotoxicity under certain conditions. Microglial 'priming' by macrophage colony stimulatory factor (MCSF) or interferon-gamma (IFN gamma) appears to be required for this fA beta-induced microglia mediated neurotoxicity in vitro. We report here that while both MCSF and IFN gamma induce microglial-mediated fA beta neurotoxicity, their mechanisms of toxicity differ. The enhancement of neurotoxicity by IFN gamma or MCSF is not due to enhanced A beta ingestion by microglia or to the direct effect of proinflammatory cytokine production. The neurotoxicity resulting from IFN gamma/fA beta treatment was blocked by pretreatment with nitric oxide synthase inhibitor L-N-5-(1-iminoethyl) ornithine hydrochloride (L-NIO), consistent with a role for nitric oxide in the IFN gamma-mediated toxicity mechanism. In contrast, no induction of nitric oxide production was detected for microglia treated with MCSF/fA beta. Furthermore, inhibiting the generation of reactive oxygen species (ROS) using the specific NADPH oxidase inhibitor apocynin reversed fA beta/MCSF-induced neurotoxicity while L-NIO had little effect. As MCSF is endogenously expressed within the brain, and both its level and that of the MCSF receptor are dramatically increased in the AD brain, the neurotoxicity resulting from ROS release by fA beta/MCSF coactivated microglia may be a more appropriate model for assessing fA beta-induced microglial-mediated neuropathology in AD.
Insights
Microglia activation by beta-amyloid in Alzheimer's disease (AD) can be toxic. Interferon-gamma (IFN gamma) triggers nitric oxide production, while macrophage colony-stimulating factor (MCSF) triggers reactive oxygen species (ROS) for neurotoxicity.
Area of Science:
- Neuroscience
- Immunology
- Alzheimer's Disease Research
Background:
- Microglia, the brain's immune cells, can cause neuronal damage when overstimulated.
- Fibrillar beta-amyloid (fAβ) peptide, a hallmark of Alzheimer's disease (AD), can induce microglial neurotoxicity.
- Microglial priming by macrophage colony-stimulating factor (MCSF) or interferon-gamma (IFNγ) is necessary for fAβ-induced neurotoxicity in vitro.
Purpose of the Study:
- To investigate the distinct mechanisms by which MCSF and IFNγ prime microglia for fAβ-induced neurotoxicity.
- To determine the roles of nitric oxide (NO) and reactive oxygen species (ROS) in these distinct neurotoxic pathways.
Main Methods:
- Primary microglia were treated with fAβ alone, or in combination with MCSF or IFNγ.
- Neurotoxicity was assessed, and the involvement of NO and ROS was investigated using specific inhibitors (L-NIO for nitric oxide synthase and apocynin for NADPH oxidase).
Main Results:
- Both MCSF and IFNγ enhanced fAβ-induced microglial neurotoxicity, but through different pathways.
- IFNγ/fAβ-induced neurotoxicity was mediated by nitric oxide (NO), as evidenced by blockage with L-NIO.
- MCSF/fAβ-induced neurotoxicity was mediated by reactive oxygen species (ROS), as evidenced by blockage with apocynin; NO was not involved.
Conclusions:
- IFNγ and MCSF utilize distinct molecular mechanisms (NO vs. ROS) to mediate fAβ-induced microglial neurotoxicity.
- The MCSF-mediated ROS pathway is particularly relevant to AD neuropathology, given increased MCSF levels in the AD brain.
- Targeting ROS production in MCSF-primed microglia may offer a therapeutic strategy for AD.
